Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are interested in the identification of novel drug targets using systems-level approaches such as phenotypic screens and chemical proteomics as well as the structure-based design of highly selective tool compounds for validation of new potential drug targets.

Our team